Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars H Pinborg

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Neuromolecular Medicine|March 13, 2016
Changes in Binding of [(123)I]CLINDE, a High-Affinity Translocator Protein 18 kDa (TSPO) Selective Radioligand in a Rat Model of Traumatic Brain InjuryCornelius K Donat, Khaled Gaber, Jürgen Meixensberger, et al.
Neuroimage|December 19, 2006
[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference regionLars H Pinborg, Charlotte Videbaek, Morten Ziebell, et al.
Neurochemical Research|August 16, 2019
Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug TargetChristoffer Mertz, Sara Krarup, Cecilie D Jensen, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophreniaHans Rasmussen, Bjørn H Ebdrup, Bodil Aggernaes, et al.
Frontiers in Aging Neuroscience|October 4, 2021
Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's DiseaseClaudia Salcedo, Jens V Andersen, Kasper Tore Vinten, et al.
Biological Psychiatry|April 4, 2006
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and genderBirte Y Glenthoj, Torben Mackeprang, Claus Svarer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 8, 2005
Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusionLars H Pinborg, Morten Ziebell, Vibe G Frøkjaer, et al.
Epilepsia|August 16, 2013
Source localization of rhythmic ictal EEG activity: a study of diagnostic accuracy following STARD criteriaSándor Beniczky, Göran Lantz, Ivana Rosenzweig, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 7, 2003
Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approachLars H Pinborg, Karen H Adams, Claus Svarer, et al.
Ugeskrift for Laeger|November 18, 2015
[Workup and treatment of autoimmune encephalitis]Morten Blaabjerg, Camilla C Mærsk-Møller, Daniel Kondziella, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Neuromolecular Medicine|March 13, 2016
Changes in Binding of [(123)I]CLINDE, a High-Affinity Translocator Protein 18 kDa (TSPO) Selective Radioligand in a Rat Model of Traumatic Brain InjuryCornelius K Donat, Khaled Gaber, Jürgen Meixensberger, et al.
Neuroimage|December 19, 2006
[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference regionLars H Pinborg, Charlotte Videbaek, Morten Ziebell, et al.
Neurochemical Research|August 16, 2019
Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug TargetChristoffer Mertz, Sara Krarup, Cecilie D Jensen, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophreniaHans Rasmussen, Bjørn H Ebdrup, Bodil Aggernaes, et al.
Frontiers in Aging Neuroscience|October 4, 2021
Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's DiseaseClaudia Salcedo, Jens V Andersen, Kasper Tore Vinten, et al.
Biological Psychiatry|April 4, 2006
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and genderBirte Y Glenthoj, Torben Mackeprang, Claus Svarer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 8, 2005
Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusionLars H Pinborg, Morten Ziebell, Vibe G Frøkjaer, et al.
Epilepsia|August 16, 2013
Source localization of rhythmic ictal EEG activity: a study of diagnostic accuracy following STARD criteriaSándor Beniczky, Göran Lantz, Ivana Rosenzweig, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 7, 2003
Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approachLars H Pinborg, Karen H Adams, Claus Svarer, et al.
Ugeskrift for Laeger|November 18, 2015
[Workup and treatment of autoimmune encephalitis]Morten Blaabjerg, Camilla C Mærsk-Møller, Daniel Kondziella, et al.
Pageof 9